iRhythm Holdings, Inc. Capital Expenditures Incurred but Not yet Paid
iRhythm Holdings, Inc. (IRTC) reported Capital Expenditures Incurred but Not yet Paid of $1.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$1.41M, a 129.60% decline year-over-year.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $2.53M, a 1817.42% increase year-over-year.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$3.27M, a 3305.88% decline year-over-year.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$1.21M.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $407.00K, a 48.00% increase from fiscal 2024.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $275.00K, a 85.43% decline from fiscal 2023.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $1.89M, a 1080.00% increase from fiscal 2022.
- iRhythm Holdings, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $160.00K, a 1677.78% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.12M 10-Q · filed 2026-08-06 | -$2.15M derived: sum of 3 quarters · filed 2026-08-06 | -$3.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.53M 10-Q · filed 2026-04-30 | -$739.00K derived: sum of 2 quarters · filed 2026-04-30 | -$1.95M derived: sum of 3 quarters · filed 2026-04-30 | $2.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$4.48M derived: sum of 2 quarters · filed 2026-02-19 | $275.00K derived: sum of 3 quarters · filed 2026-08-06 | $407.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.54M derived: sum of 2 quarters · filed 2026-08-06 | $3.68M 10-Q · filed 2025-10-30 | $3.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.88M 10-Q · filed 2026-08-06 | $4.99M derived: sum of 3 quarters · filed 2026-08-06 | $4.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $132.00K 10-Q · filed 2026-04-30 | $234.00K derived: sum of 2 quarters · filed 2026-04-30 | $174.00K derived: sum of 3 quarters · filed 2026-04-30 | $384.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $42.00K derived: sum of 2 quarters · filed 2026-02-19 | $252.00K derived: sum of 3 quarters · filed 2026-02-19 | $275.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $150.00K derived: sum of 2 quarters · filed 2025-10-30 | $173.00K 10-Q · filed 2025-10-30 | $1.97M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $233.00K 10-Q · filed 2025-07-31 | $2.03M derived: sum of 3 quarters · filed 2026-02-19 | $2.01M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $23.00K 10-Q · filed 2025-05-01 | $1.82M derived: sum of 2 quarters · filed 2026-02-19 | $1.80M derived: sum of 3 quarters · filed 2026-02-19 | $1.71M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.78M derived: sum of 2 quarters · filed 2026-02-19 | $1.69M derived: sum of 3 quarters · filed 2026-02-19 | $1.89M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$114.00K derived: sum of 2 quarters · filed 2024-10-30 | $89.00K 10-Q · filed 2024-10-30 | -$930.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $107.00K 10-Q · filed 2024-08-01 | -$912.00K derived: sum of 3 quarters · filed 2025-02-20 | $267.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $203.00K 10-Q · filed 2024-05-02 | -$816.00K derived: sum of 2 quarters · filed 2025-02-20 | $363.00K derived: sum of 3 quarters · filed 2025-02-20 | $138.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $160.00K derived: sum of 2 quarters · filed 2025-02-20 | -$65.00K derived: sum of 3 quarters · filed 2025-02-20 | $160.00K 10-K · filed 2025-02-20 |
| 2022-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $954.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.18M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | -$225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $225.00K 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $9.00K 10-K · filed 2024-02-22 | |||
| 2020-12-31 | $3.00K 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |